API 31510
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for API 31510, covering 2019-02-15 to 2019-02-15. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS) [Phase 1, Phase 2]